BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12440876)

  • 1. Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan biosynthesis.
    Helm JS; Chen L; Walker S
    J Am Chem Soc; 2002 Nov; 124(47):13970-1. PubMed ID: 12440876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II.
    Hu Y; Helm JS; Chen L; Ye XY; Walker S
    J Am Chem Soc; 2003 Jul; 125(29):8736-7. PubMed ID: 12862463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of ramoplanin and enduracidin.
    Fang X; Tiyanont K; Zhang Y; Wanner J; Boger D; Walker S
    Mol Biosyst; 2006 Jan; 2(1):69-76. PubMed ID: 16880924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin.
    Cudic P; Behenna DC; Kranz JK; Kruger RG; Wand AJ; Veklich YI; Weisel JW; McCafferty DG
    Chem Biol; 2002 Aug; 9(8):897-906. PubMed ID: 12204689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic lipid preferences and kinetic mechanism of Escherichia coli MurG.
    Chen L; Men H; Ha S; Ye XY; Brunner L; Hu Y; Walker S
    Biochemistry; 2002 May; 41(21):6824-33. PubMed ID: 12022887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptor specificity and inhibition of the bacterial cell-wall glycosyltransferase MurG.
    Liu H; Ritter TK; Sadamoto R; Sears PS; Wu M; Wong CH
    Chembiochem; 2003 Jul; 4(7):603-9. PubMed ID: 12851929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E. Coli MurG: a paradigm for a superfamily of glycosyltransferases.
    Ha S; Gross B; Walker S
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):201-13. PubMed ID: 12455415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of peptidoglycan biosynthesis by ramoplanin.
    Somner EA; Reynolds PE
    Antimicrob Agents Chemother; 1990 Mar; 34(3):413-9. PubMed ID: 2334153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry and biology of the ramoplanin family of peptide antibiotics.
    McCafferty DG; Cudic P; Frankel BA; Barkallah S; Kruger RG; Li W
    Biopolymers; 2002; 66(4):261-84. PubMed ID: 12491539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.
    Ravishankar S; Kumar VP; Chandrakala B; Jha RK; Solapure SM; de Sousa SM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1410-8. PubMed ID: 15793120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multitarget assay for inhibitors of membrane-associated steps of peptidoglycan biosynthesis.
    Barbosa MD; Ross HO; Hillman MC; Meade RP; Kurilla MG; Pompliano DL
    Anal Biochem; 2002 Jul; 306(1):17-22. PubMed ID: 12069409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation.
    Cudic P; Kranz JK; Behenna DC; Kruger RG; Tadesse H; Wand AJ; Veklich YI; Weisel JW; McCafferty DG
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7384-9. PubMed ID: 12032292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity.
    Walker S; Chen L; Hu Y; Rew Y; Shin D; Boger DL
    Chem Rev; 2005 Feb; 105(2):449-76. PubMed ID: 15700952
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
    Reynolds PE; Somner EA
    Drugs Exp Clin Res; 1990; 16(8):385-9. PubMed ID: 2151441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics.
    Chen L; Yuan Y; Helm JS; Hu Y; Rew Y; Shin D; Boger DL; Walker S
    J Am Chem Soc; 2004 Jun; 126(24):7462-3. PubMed ID: 15198592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biosynthesis of peptidoglycan lipid-linked intermediates.
    Bouhss A; Trunkfield AE; Bugg TD; Mengin-Lecreulx D
    FEMS Microbiol Rev; 2008 Mar; 32(2):208-33. PubMed ID: 18081839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen.
    Helm JS; Hu Y; Chen L; Gross B; Walker S
    J Am Chem Soc; 2003 Sep; 125(37):11168-9. PubMed ID: 16220917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate analogues to study cell-wall biosynthesis and its inhibition.
    Lazar K; Walker S
    Curr Opin Chem Biol; 2002 Dec; 6(6):786-93. PubMed ID: 12470732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and biochemical analysis of a key series of ramoplanin analogues.
    Fang X; Nam J; Shin D; Rew Y; Boger DL; Walker S
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6189-91. PubMed ID: 19783144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A MurG assay which utilises a synthetic analogue of lipid I.
    Auger G; van Heijenoort J; Mengin-Lecreulx D; Blanot D
    FEMS Microbiol Lett; 2003 Feb; 219(1):115-9. PubMed ID: 12594032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.